20247 ⎘
Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
IMPROVED COGNITIVE SUPPLEMENTS
#1502OIL BODY EXTRACTION AND USES
#1503Infant formula with a low content of MCFAS in specific proportions and a relatively high content of unsaturated fatty acids, and its use in promoting the healthy establishment of cognitive function in infants
#1504Compositions and methods for treating non-alcoholic steatohepatitis
#1505PRENATAL AND LACTATION SUPPLEMENTS TO ENHANCE CENTRAL NERVOUS SYSTEM DEVELOPMENT OF OFFSPRING
#1506Infant nutritional product with RRR alpha-tocopherol
#1507Lipid compositions containing bioactive fatty acids
#1508Operational control of fuel cells
#1509METHODS AND COMPOSITIONS FOR PROMOTING THE NEUROLOGICAL DEVELOPMENT OF AN INFANT
#1510Mixture of fatty acids for use in the treatment of inflammatory pathologies
#1511Low density lipoprotein nanocarriers for targeted delivery of omega-3 polyunsaturated fatty acids to cancer
#1512Nutritional supplement/feed formula and methods of use thereof to reduce development of Osteochondrosis Dissecans (OCD) lesions
#1513Composition for enhancing newborn infant cognitive, brain and/or CNS development and method of using same
#1514Methods of treating ototoxicity
#1515Methods for increasing oral osteogenesis using lipoxin A4 (LXA4) and its analogs
#1516Enhanced bioavailability of polyunsaturated fatty acids
#1517TREATMENT OF PETS WITH SIRTUIN ACTIVATORS
#1518Method for increasing performance of offspring
#1519Lipid comprising docosapentaenoic acid
#1520Treatment of Severe Hypertriglyceridemia
#1521Mineral amino-acid complexes of fatty acids
#1522Synbiotics combination for brain improvement
#1523ALL-NATURAL ENTERIC SOFT CAPSULES COMPRISING ACTIVE INGREDIENTS
#1524Method for producing polyunsaturated fatty acids in transgenic plants
#1525COMBINATION METHODS AND COMPOSITIONS INCLUDING SLEEP THERAPEUTICS FOR TREATING MOOD
#1526Low protein infant formula with increased essential amino acids
#1527Use of protectin DX for the stimulation of muscular IL-6 secretion
#1528Oral formulations of bipolar trans carotenoids
#1529Pharmaceutical compositions comprising DGLA and use of same
#1530Metabolism-improving agent comprising rare fatty acid
#1531CYP450 lipid metabolites reduce inflammation and angiogenesis
#1532Preventing diseases in infants delivered via caesarean section
#1533Medical formulation for treating hypercholesterolemia
#1534Non-medical increase or maintenance of body weight of a mammal
#1535COMPOSITION AND METHOD TO IMPROVE BLOOD LIPID PROFILES AND REDUCE LOW DENSITY LIPOPROTEIN (LDL) PER-OXIDATION IN HUMANS USING ALGAE BASED OILS AND ASTAXANTHIN
#1536DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
#1537Powderous formulation
#1538Production of DHA and other LC PUFAs in plants
#1539Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
#1540Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
#1541INFANT NUTRITION FOR IMPROVING FATTY ACID COMPOSITION OF BRAIN MEMBRANES
#1542Gummy compositions for nutritional supplementation
#1543Compositions and methods for the treatment inflammation and lipid disorders
#1544Product and method for supporting uridine homeostasis
#1545Composition comprising a combination of DHA and EPA for administration prior to commencement of chemotherapy
#1546Visual performance and/or macular pigmentation
#1547Soft gelatin encapsulated pharmaceutical composition of cis-5,8,11,14,17-eicosapentaenoic acid in free acid form and cis-7,10,13,16,19-docosapentaenoic acid in free acid form
#1548Use of TRPV4 antagonists to ameliorate hydrocephalus and related materials and methods
#1549GUMMY COMPOSITIONS FOR NUTRITIONAL SUPPLEMENTATION
#1550Self-emulsifying composition of ω3 fatty acid
#1551Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
#1552Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and joint care components, including type II collagen
#1553Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour
#1554Compositions, methods and kits for treating cancer
#1555Use of an Omega-3 Lipid-Based Emulsion Following Ischemic Injury to Provide Protection and Recovery in Human Organs
#1556METHOD FOR ALLEVIATING FEAR MEMORY
#1557Pharmaceutical compositions comprising omega-3 fatty acids
#1558MEDICAMENT COMPRISING AT LEAST ONE OMEGA-3 POLYUNSATURATED FATTY ACID
#1559Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
#1560METHODS OF INCREASING EPA BLOOD LEVELS
#1561METHOD FOR REDUCING TRIGLYCERIDES
#1562Medicinal composition of extract of seed of Emblica officinalis and method of preparing the same
#1563Composition for reducing new-onset diabetes
#1564Methods, compositions, and devices for supplying dietary fatty acid needs
#1565Nitrated lipids and methods of making and using thereof
#1566Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
#1567OMEGA 3 FATTY ACID FOR USE AS A PRESCRIPTION MEDICAL FOOD AND OMEGA 3 FATTY ACID DIAGNOSTIC ASSAY FOR THE DIETARY MANAGEMENT OF CARDIOVASCULAR PATIENTS WITH CARDIOVASCULAR DISEASE (CVD) WHO ARE DEFICIENT IN BLOOD EPA AND DHA LEVELS
#1568Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, protein and low levels of electrolytes
#1569Semifluorinated alkane compositions
#1570COMPOSITION AND METHOD FOR TREATING MIGRAINES
#1571Modulators of androgen synthesis
#1572STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME
#1573PHARMACEUTICAL COMPOSITION
#1574SOFT ELASTIC CAPSULES CONTAINING TABLETS AND LIQUID OR SEMISOLID FILLS AND METHODS FOR THEIR MANUFACTURE
#1575INFANT FORMULA FOR OPTIMAL GROWTH, GASTROINTESTINAL PROTECTION AND IMMUNOLOGICAL PROTECTION OF INFANTS
#1576Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
#1577COMPOSITION USING SEED OIL EXTRACTS AND PHOSPHOLIPIDS TO ENHANCE ABSORPTION OF CAROTENOIDS AND ASSOCIATED METHODS
#1578Methods of treating mixed dyslipidemia
#1579Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
#1580Sn-2-monoacylgycerols and lipid malabsorption
#1581COMPOSITIONS COMPRISING 15-OHEPA AND METHODS OF USING THE SAME
#1582OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH
#1583STABLE FORMULATIONS OF FATTY ACIDS
#1584Dietary supplement containing phospholipid-DHA derived from eggs
#1585Compounds and methods for modulating vascular injury
#1586Production of omega-3 long chain polyunsaturated fatty acids
#1587Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains
#1588Niacin conjugated fatty acid mixtures and their uses
#1589MULTI-COMPONENT FORMULATION FOR IMPROVING NEUROLOGICAL FUNCTION
#1590RETINOIDS AND USE THEREOF
#1591PHARMACEUTICAL COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF TREATING ASTHMA AND LUNG DISORDERS USING SAME
#1592Pediatric nutritional composition with milk peptides for healthy growth and development
#1593Compositions for the treatment of diabetes and pre-diabetes
#1594Composition and method to alleviate joint pain using phospholipids and roe extract
#1595Composition and method to alleviate joint pain using phospholipids and astaxanthin
#1596Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
#1597DIETARY AND NUTRITIONAL COMPOSITIONS AND METHODS OF USE
#1598Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient
#1599FISH FEED, METHODS FOR PREPARING FEED, AND FEEDING FISH
#1600Therapeutic astaxanthin and phospholipid composition and associated method
#1601Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
#1602TOPICAL FORMULATIONS AND USES THEREOF
#1603Preparation for improving the action of receptors
#1604STABILIZED FORMULATIONS OF FATTY ACIDS
#1605Topical compositions comprising polyunsaturated fatty acids
#1606CONCENTRATION OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN KRILL OIL
#1607NUTRITIONAL COMPOSITION CONTAINING A NEUROLOGIC COMPONENT OF URSOLIC ACID AND USES THEREOF
#1608PURIFICATION OF DPA ENRICHED OIL
#1609Bioeffective krill oil compositions
#1610Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders
#1611NUTRITIONAL PRODUCTS AND METHODS OF IMPROVING EXERCISE PERFORMANCE AND REDUCING EXERCISE INDUCED IMPAIRMENT OF IMMUNE FUNCTION
#1612Chemosensory receptor ligand-based therapies
#1613Compositions, methods and kits for treating cancer
#1614Composition and method for treatment of NASH
#1615Solid oral dosage form for breast symptoms
#1616Asthmatic and Allergenic Nutritional Composition
#1617Cardiovascular disease primary prevention agent for patients having high blood levels of high-sensitivity C-reactive protein
#1618Compositions and methods for the treatment of moderate to severe pain
#1619SYNERGISTIC CANCER THERAPY DRUG COMBINATIONS
#1620COMPOSITIONS FOR AMELIORATING A REDUCED HIGHER BRAIN FUNCTION RESULTING FROM ORGANIC BRAIN LESIONS
#1621PURIFICATION OF DPA ENRICHED OIL
#1622EMULSION COMPRISING POLYUNSATURATED FATTY ACIDS
#1623Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
#1624Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
#1625Nutritional Compositions and Methods for Treating Cognitive Impairment
#1626Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
#1627Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors
#1628Compositions and methods for the treatment of asthma and allergy
#1629CUSTOM-FORMULATED PHOSPHOLIPID MICROBUBBLES AND METHODS AND USES THEREOF
#1630POLYUNSATURATED FATTY ACIDS FOR TREATMENT OF DEMENTIA AND PRE-DEMENTIA-RELATED CONDITIONS
#163114-hydroxy-docosahexaenoic acid compounds
#163214-hydroxy-docosahexaenoic acid compounds
#163314-hydroxy-docosahexaenoic acid compounds
#1634Compositions and methods for the treatment of local pain
#1635STATIN AND OMEGA 3 FATTY ACIDS FOR REDUCTION OF APOLIPOPROTEIN-B LEVELS
#1636CHOLESTEROL ABSORPTION INHIBITOR AND OMEGA 3 FATTY ACIDS FOR THE REDUCTION OF CHOLESTEROL AND FOR THE PREVENTION OR REDUCTION OF CARDIOVASCULAR, CARDIAC AND VASCULAR EVENTS
#1637NUTRITIONAL COMPOSITIONS CONTAINING A PREBIOTIC AND LACTOFERRIN AND USES THEREOF
#1638Enteric soft capsules comprising polyunsaturated fatty acids
#1639METHODS AND KITS FOR ENHANCING THE ABILITY TO LEARN IN A PUPPY OR KITTEN
#1640COMPLEXES AND COMPOSITIONS CONTAINING CURCUMIN
#1641Compositions of statins and omega-3 fatty acids
#1642COMPLEXES AND COMPOSITIONS CONTAINING CURCUMIN
#1643USE OF RNA INTERFEARENCE, FARNESOIC ACID AND RECOMBINANT PROTEIN APPROACH TO INDUCE GONAD MATURATION IN CRUSTACEAN SPECIES
#1644PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF REDUCING SEBUM PRODUCTION USING SAME
#1645USE OF NUTRITIONAL COMPOSITIONS FOR PREVENTING DISORDERS
#1646Nutritional composition containing a peptide component with anti-inflammatory properties and uses thereof
#1647Formulations and methods for treatment of acne and inflammatory skin conditions
#1648Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof
#1649Formulations and methods for treatment of inflammatory skin diseases
#1650NUTRACEUTICALS CONTAINING NITRO FATTY ACIDS
#1651PHARMACEUTICAL COMPOSITIONS COMPRISING DHA, EPA, AND/OR GLA AND AN ANTIBIOTIC AGENT AND METHODS OF USE THEREOF
#1652COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS AND VITAMIN D FOR ACNE VULGARIS AND/OR ECZEMA, AND METHODS AND USES THEREOF
#1653Formulations and methods for treatment of wounds and inflammatory skin conditions
#1654Methods for weight loss and ketogenic compositions
#1655METHODS OF TREATING OR PREVENTING PROSTATE CANCER
#1656production of ultrapure EPA and polar lipids form largely heterotrophic culture
#1657Methods for treating inflammatory diseases with compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof
#1658Compositions and methods for the treatment of inflammation and lipid disorders
#1659FOOD SUPPLEMENT TO SUPPORT BRAIN FUNCTION
#1660Compositions comprising omega-3 fatty acids and vitamin D for psoriasis, and methods and uses thereof
#1661Lipid-lowering antidiabetic agent
#1662Supplement composition and method of use
#1663Supplement composition and methods of use
#1664DIETARY AND NUTRITIONAL SUPPLEMENTS CONTAINING AN OMEGA-3 FATTY ACID OF PLANT-BASED ORIGIN AND A FOLATE DERIVATIVE
#1665Pomegranate oil for preventing and treating neurodegenerative diseases
#1666COMPOSITION FOR IMPROVING NEUROPSYCHOLOGICAL TEST BATTERY SCORE
#1667METHOD FOR IMPROVING FUNCTIONAL SYNAPTIC CONNECTIVITY
#1668Orodispersible composition comprising polyunsaturated fatty acids without bad odor or taste
#1669Nutritional compositions containing synergistic combination and uses thereof
#1670PREPARATION FOR IMPROVING THE ACTION OF RECEPTORS
#1671Quaternary ammonium anti-cholinergic muscarinic receptor antagonists
#1672Method of treating, delaying and/or preventing Alzheimer's Disease
#1673COMPOSITION FOR POLYUNSATURATED FATTY ACIDS ENCAPSULATION AND PROCESS OF PREPARATION
#1674NUTRITIONAL COMPOSITIONS INCLUDING RRR-ALPHA TOCOPHEROL AND POLYUNSATURATED FATTY ACIDS
#1675Methods for enhancing, improving, or increasing fertility or reproductive function
#1676Anti-infective antimicrobial-containing biomaterials
#1677Methods for promoting neuronal development and/or health
#1678Methods for promoting neuronal development and/or health
#1679FATTY ACIDS AS ANTI-INFLAMMATORY AGENTS
#1680Combination of a leucine source and an omega-3 unsaturated fatty acid source for use in the treatment of hypercalcaemia
#1681Methods and products to provide oral nutritional care to subjects with dementia
#1682Methods of treating amyotrophic lateral sclerosis
#1683Methods for Identifying and Treating an Individual with an Inflammatory Disease using Fatty Acid-Based Therapies
#1684Bioeffective krill oil compositions
#1685Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof
#1686DPA-ENRICHED COMPOSITIONS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN FREE ACID FORM
#1687Bioeffective krill oil compositions
#1688Nutritional composition for improving the mammalian immune system
#1689Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof
#1690METHODS OF IMPROVING BONE HEALTH AND MUSCLE HEALTH
#1691PREPARED FOODS HAVING HIGH EFFICACY OMEGA-6/OMEGA-3 BALANCED POLYUNSATURATED FATTY ACIDS
#1692COMPOSITION FOR PREVENTING THE OCCURRENCE OF CARDIOVASCULAR EVENT IN MULTIPLE RISK PATIENT
#1693Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
#1694Salts of potassium ATP channel openers and uses thereof
#1695Esters for treatment of ocular inflammatory conditions
#1696TWO PART FORMULATION SYSTEM FOR OPHTHALMIC DELIVERY
#1697Methods of using omega-3 fatty acids
#1698Compositions for the treatment of diabetes and pre-diabetes
#1699Organic emulsion comprising DHA and EPA
#1700COMPOSITION FOR TREATMENT OR REDUCTION OF SYMPTOMS RELATED TO PREMENSTRUAL SYNDROME (PMS), PREMENSTRUAL DISPHORIC DISORDER (PMDD), PREMENOPAUSE, MENOPAUSE OR FEMALE HORMONAL DISORDERS, IN A PHARMACEUTICAL COMPOSITION CONTAINING SAID FORM, AND PROCESS FOR PRODUCING SAID PHARMACEUTICAL FORM AND USE OF SAID COMPOSITION
#1701Antibiotic composition comprising a chemotactic agent and a nutrient dispersion
#1702Methods of Improving Bone Health and Muscle Health
#1703Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
#1704Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsules
#1705Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases
#1706Methods of treating impaired glucose metabolism via administration of algal biomass
#1707Prevention of psychotic disorders and/or treatment of psychotic symptoms
#1708MICROBIAL OILS ENRICHED IN POLYUNSATURATED FATTY ACIDS
#1709Omega-3 Fatty Acid Formulations for Use as Pharmaceutical Treatment
#1710METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ATTENTION DEFICIT HYPERACTIVITY DISORDER
#1711Treatment and prevention of bone loss using resolvins
#1712USE OF INTRACELLULAR ENZYMES FOR THE RELEASE OF COVALENTLY LINKED BIOACTIVES
#1713Use of PUFAS for treating skin inflammation
#1714Dietary product intended to reduce visceral fat during the pre-operative phase prior to bariatric surgery
#1715Krill oil and reacted astaxanthin composition and associated method
#1716Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease
#1717COMPOUNDS WITH ANTI-AGING ACTIVITIES
#1718NUTRITIONAL COMPOSITION COMPRISING IMMUNOGLOBULINS AND OLIGOSACCHARIDES
#1719Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
#1720Nutritional Composition
#1721Glycogen or polysaccharide storage disease treatment method
#1722COMPOSITIONS OF CRUDE ALGAL OIL
#1723Fatty acid composition and plant extract and pharmaceutical preparation and application thereof
#1724VETERINARY SUPPLEMENTS
#1725Dietary product intended for the prevention of cardiometabolic risk
#1726Use of an Omega-3 Lipid-Based Emulsion Following Ischemic Injury to Provide Protection and Recovery in Human Organs
#1727Composition for use in increasing insulin sensitivity and/or reducing insulin resistance
#1728COMPOSITION FOR USE IN THE PROMOTION OF INTESTINAL ANGIOGENESIS AND OF NUTRIENT ABSORPTION AND OF ENTERAL FEEDING TOLERANCE AND/OR IN THE PREVENTION AND/OR TREATMENT OF INTESTINAL INFLAMMATION AND/OR IN THE RECOVERY AFTER INTESTINAL INJURY AND SURGERY
#1729Compositions and methods for treating or preventing obesity in a subject in need thereof
#1730METHODS OF TREATING TRAUMATIC BRAIN INJURY
#1731Composition for external use on skin for inflammatory diseases
#1732Improving recognition
#1733ALGAL OMEGA 7 COMPOSITIONS
#1734COMPOSITION AND METHOD FOR TREATING NEUROPATHY
#1735COMPOSITIONS CONTAINING NITRO FATTY ACIDS
#1736Acid stable liposomal compositions and methods for producing the same
#1737Compositions and methods for utilization of algal compounds
#1738Formulations of water-soluble derivatives of vitamin E and compositions containing same
#1739COMPOSITION FOR USE IN BRAIN GROWTH AND/OR COGNITIVE AND/OR PSYCHOMOTOR DEVELOPMENT
#1740Activating adiponectin by casein hydrolysate
#1741Reducing proinflammatory response
#1742Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
#1743Nutritional compositions containing a peptide component and uses thereof
#1744METHODS FOR THE TREATMENT OF BRAIN INJURY USING OMEGA-3 FATTY ACIDS
#1745COMPOSITIONS COMPRISING EICOSAPENTAENOIC ACID AND A HYDROXYL COMPOUND AND METHODS OF USE THEREOF
#1746Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#1747METHOD FOR IMPROVING EXECUTIVE FUNCTION
#1748Composition for use in the promotion of magnesium absorption and/or magnesium retention
#1749Dietary supplement composition
#1750Lipid composition for the prevention or treatment of skin problems
#1751METHODS OF ADMINISTERING COMPOSITIONS COMPRISING DOCOSAPENTAENOIC ACID
#1752METHODS OF REDUCING OR PREVENTING OXIDATIVE MODIFICATION OF MEMBRANE POLYUNSATURATED FATTY ACIDS
#1753Fatty acid niacin conjugates and their uses
#1754ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES
#1755Enhancement Composition
#1756Composition for use in the promotion of healthy bone growth and/or in the treatment of bone disease
#1757Compositions containing non-polar compounds
#1758Stable pharmaceutical composition and methods of using same
#1759PHARMACEUTICAL METHODS AND TOPICAL COMPOSITIONS CONTAINING ACITRETIN
#1760Botanical formulations
#1761Type A gelatin capsule containing PUFA in free acid form
#1762Fatty acid niacin conjugates and their uses
#1763Use of omega fatty acids for treating disease
#1764Composition containing non-polar compounds
#1765In vivo method for treating, inhibiting, and/or prophylaxis of cancer, such as pancreatic cancer
#1766Use Of Xanthophyll Carotenoids To Improve Visual Performance And Neural Efficiency
#1767Stabilized formulation comprising omega-3 fatty acids and use of the fatty acids for skin care and/or wound care
#1768METHODS OF INCREASING EPA BLOOD LEVELS
#1769TREATMENT OF INFLAMMATORY DISEASE OR DISORDER AND COMPOSITIONS THEREFOR
#1770COATED SUPPOSITORIES
#1771COMPOSITION AND METHOD TO IMPROVE BLOOD LIPID PROFILES AND REDUCE LOW DENSITY LIPOPROTEIN (LDL) PER-OXIDATION IN HUMANS USING ALGAE BASED OILS AND ASTAXANTHIN
#1772METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING OSTEOARTHRITIS
#1773Method for reducing the occurrence of infection in young children
#1774Nutritional compositions containing magnesium threonate and uses thereof
#1775KRILL AND/OR MARINE EXTRACTS FOR PREVENTION AND/OR TREATMENT OF CARDIOVASCULAR DISEASES, ARTHRITIS, SKIN CANCER, DIABETES, PREMENSTRUAL SYNDROME AND TRANSDERMAL TRANSPORT
#1776THERAPEUTIC STEM CELL NUTRIENT COMPOSITION AND USES THEREOF
#1777Composition and method to alleviate joint pain using algae based oils
#1778COMPOSITIONS COMPRISING DOCOSAPENTAENOIC ACID AND METHODS OF USE
#1779Dietary formulations and methods for treatment of inflammation and other disorders
#1780Use of pufas for treating skin inflammation
#1781Pluripotent therapeutic compositions and uses thereof
#1782Metabolic imprinting effects of specifically designed lipid component
#1783DHA AND EPA IN THE REDUCTION OF OXIDATIVE STRESS
#1784Compositions comprising EPA and obeticholic acid and methods of use thereof
#1785NEUROGENESIS SCREENING METHOD AND USES THEREOF
#1786Eicosapentaenoic acid (EPA) formulations
#1787Use of docasatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma
#1788Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (LDL) per-oxidation in humans
#1789Medicinal skin protection composition with an active ingredient combination which improves the skin barrier
#1790NUTRITIONAL COMPOSITIONS COMPRISING HIGH OLEIC ACID CANOLA OIL
#1791Health promoting drink
#1792ANTIMICROBIAL COMPOSITIONS COMPRISING DGLA AND NEOMYCIN SULFATE AND METHODS OF USE THEREOF
#1793Compositions and methods for treating traumatic brain injury
#1794Solid solution compositions and use in chronic inflammation
#1795Compositions for treating chronic inflammation and inflammatory diseases
#1796PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME
#1797Anti-obesity agent comprising high-purity EPA
#1798Pharmaceutical compositions comprising fatty acids
#1799SALT FORMS OF FATTY ACIDS FOR THE TREATMENT OF DRY EYE
#1800Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA